SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - INMUNE BIO INC ownership

INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 43 filers reported holding INMUNE BIO INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of INMUNE BIO INC
ValueSharesWeighting
Q4 2021$127,000
-62.0%
12,473
-27.5%
0.00%
-50.0%
Q3 2021$334,000
+106.2%
17,200
+25.9%
0.01%
+100.0%
Q1 2021$162,000
-30.5%
13,663
+1.0%
0.00%
-25.0%
Q4 2020$233,000
-14.0%
13,534
-48.5%
0.00%
-50.0%
Q3 2020$271,00026,3000.01%
Other shareholders
INMUNE BIO INC shareholders Q4 2021
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 230,500$2,351,0001.70%
Fermata Advisors, LLC 17,955$183,0000.07%
Virtu Financial LLC 24,364$249,0000.02%
YorkBridge Wealth Partners, LLC 10,369$106,0000.02%
Jump Financial, LLC 21,100$215,0000.01%
Financial Advocates Investment Management 15,167$155,0000.01%
FNY Investment Advisers, LLC 1,100$11,0000.01%
Janney Montgomery Scott LLC 113,914$1,162,0000.01%
Walleye Capital LLC 17,127$175,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 12,473$127,0000.00%
View complete list of INMUNE BIO INC shareholders